FdaApplication
NDA 020844
Identifiers
- fda_app_no: NDA020844
Properties
| Property | Value |
|---|---|
| applicant_name | JANSSEN PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 1998-10-26 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOPAMAX | TOPIRAMATE | 25MG | CAPSULE;ORAL |
| TOPAMAX | TOPIRAMATE | 15MG | CAPSULE;ORAL |
| TOPAMAX SPRINKLE | TOPIRAMATE | 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
3 products